80 related articles for article (PubMed ID: 23933788)
1. Decreased expression of SOX9 in intraductal papillary mucinous neoplasms of the bile duct.
Kuroki T; Tanaka T; Kitasato A; Adachi T; Ono S; Hirabaru M; Takatsuki M; Eguchi S
Hepatogastroenterology; 2013 Oct; 60(127):1573-6. PubMed ID: 23933788
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
[TBL] [Abstract][Full Text] [Related]
4. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological spectrum and management of intraductal papillary mucinous neoplasm of the bile duct (IPMN-B).
D'souza MA; Isaksson B; Löhr M; Enochsson L; Swahn F; Lundell L; Arnelo U
Scand J Gastroenterol; 2013 Apr; 48(4):473-9. PubMed ID: 23330596
[TBL] [Abstract][Full Text] [Related]
7. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
8. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
Oda Y; Aishima S; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y
Hum Pathol; 2017 Jul; 65():71-78. PubMed ID: 28412205
[TBL] [Abstract][Full Text] [Related]
9. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases.
Tanaka M; Fukushima N; Noda N; Shibahara J; Kokudo N; Fukayama M
Hum Pathol; 2009 Nov; 40(11):1543-52. PubMed ID: 19540556
[TBL] [Abstract][Full Text] [Related]
10. Mucinous Cystic Neoplasm of the Liver or Intraductal Papillary Mucinous Neoplasm of the Bile Duct? A Case Report and a Review of Literature.
Kunovsky L; Kala Z; Svaton R; Moravcik P; Mazanec J; Husty J; Prochazka V
Ann Hepatol; 2018; 17(3):519-524. PubMed ID: 29735801
[TBL] [Abstract][Full Text] [Related]
11. Biliary tract intraductal papillary mucinous neoplasm: report of 19 cases.
Wang X; Cai YQ; Chen YH; Liu XB
World J Gastroenterol; 2015 Apr; 21(14):4261-7. PubMed ID: 25892877
[TBL] [Abstract][Full Text] [Related]
12. The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Kanno A; Satoh K; Kimura K; Hirota M; Umino J; Masamune A; Satoh A; Asakura T; Egawa S; Sunamura M; Endoh M; Shimosegawa T
Pancreas; 2006 Nov; 33(4):391-6. PubMed ID: 17079945
[TBL] [Abstract][Full Text] [Related]
13. Cystic micropapillary neoplasm of peribiliary glands with concomitant perihilar cholangiocarcinoma.
Uchida T; Yamamoto Y; Ito T; Okamura Y; Sugiura T; Uesaka K; Nakanuma Y
World J Gastroenterol; 2016 Feb; 22(7):2391-7. PubMed ID: 26900302
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation.
Takanami K; Yamada T; Tsuda M; Takase K; Ishida K; Nakamura Y; Kanno A; Shimosegawa T; Unno M; Takahashi S
Abdom Imaging; 2011 Aug; 36(4):447-56. PubMed ID: 20959978
[TBL] [Abstract][Full Text] [Related]
15. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary neoplasm of the bile duct.
Wan XS; Xu YY; Qian JY; Yang XB; Wang AQ; He L; Zhao HT; Sang XT
World J Gastroenterol; 2013 Dec; 19(46):8595-604. PubMed ID: 24379576
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
20. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
